Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
Narcisa Mesaros(UCLouvain), Françoise Van Bambeke(UCLouvain), Yves Van Laethem(Centre Hospitalier Universitaire de Saint-Pierre), Johan Van Eldere(Centre for European Policy Studies), Patrice Nordmann(University of Fribourg), Anne Malfroot(Vrije Universiteit Brussel), Patrick Lebecque(Cliniques Universitaires Saint-Luc), Patrick Plésiat(Hôpital Ambroise-Paré), M. Roussel‐Delvallez(Université de Lille), Y. Glupczynski(University of Antwerp), F. Jacobs(Erasmus Hospital), Paul M. Tulkens(UCLouvain)
Cited by 575
Related Papers
Tackling antibiotic resistance
|Nature Reviews Microbiology|2011|1.1k
Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019
|Journal of Internal Medicine|2020|847
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
|Nature Microbiology|2019|817
Dissemination of Clonally Related<i>Escherichia coli</i>Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15
|Emerging infectious diseases|2008|695
The influence of abutment surface roughness on plaque accumulation and peri‐implant mucositis
|Clinical Oral Implants Research|1996|650